🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Adriamycin and Cytoxan (AC)

Found 143 matching trials

A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)

PHASE4

This is an efficacy and safety study to compare aprepitant with ondansetron...

Status

Completed

Location

Multiple Locations

Start Date

2012-12-12

Trial ID

NCT01636947

Treatments Being Tested

Aprepitant Aprepitant Placebo Ondansetron Dexamethasone Ondansetron Placebo Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...

Status

Unknown

Location

Memorial Sloan-Kettering Cancer Center

Start Date

2006-07

Trial ID

NCT00436709

Treatments Being Tested

bevacizumab pegfilgrastim cyclophosphamide doxorubicin hydrochloride paclitaxel albumin-stabilized nanoparticle formulation flow cytometry immunoenzyme technique immunologic technique laboratory biomarker analysis adjuvant therapy immunoscintigraphy

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

PHASE3

RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...

Status

Active Not Recruiting

Location

Regional Medical Center

Start Date

2003-11

Trial ID

NCT00070564

Treatments Being Tested

pegfilgrastim AC regimen cyclophosphamide doxorubicin hydrochloride paclitaxel

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

PHASE2

This study is a multicentric trial evaluating the efficacy of R-ACVBP in pa...

Status

Completed

Location

Groupe d'Etude des Lymphomes de l'adulte

Start Date

2003-12

Trial ID

NCT00144807

Treatments Being Tested

rituximab doxorubicin cyclophosphamide autologous stem cell transplantation

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

PHASE2

This study is being conducted in patients with newly diagnosed breast cance...

Status

Completed

Location

Columbia University Irving Medical Center

Start Date

2012-10

Trial ID

NCT01847001

Treatments Being Tested

Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamide Surgery Premedication Anti-nausea therapy Pegfilgrastim

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

PHASE3

The purpose of this trial is to compare the 3-year disease-free survival of...

Status

Unknown

Location

National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College

Start Date

2019-02-22

Trial ID

NCT03876886

Treatments Being Tested

Epirubicin Cyclophosphamide Paclitaxel Carboplatin Paclitaxel

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

N/A

RATIONALE: Learning about thyroid dysfunction in patients with breast cance...

Status

Completed

Location

CCOP - Western Regional, Arizona

Start Date

2006-04

Trial ID

NCT00336102

Treatments Being Tested

physiologic testing fatigue assessment and management management of therapy complications

NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial

PHASE2

VALENTINE is a parallel, non-comparative, three-arm, randomized 1:2:2 open-...

Status

Active Not Recruiting

Location

ICO Badalona

Start Date

2022-11-25

Trial ID

NCT05569811

Treatments Being Tested

Patritumab deruxtecan Chemotherapy Letrozole

Vaccination of High Risk Breast Cancer Patients

PHASE1

The purpose of this study is to evaluate a new investigational cancer vacci...

Status

Completed

Location

Highlands Oncology Group

Start Date

2015-01-14

Trial ID

NCT02229084

Treatments Being Tested

P10s-PADRE/ MONTANIDE™ ISA 51 VG Doxorubicin Cyclophosphamide Docetaxel

A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients

PHASE2

This is a pilot feasibility trial of AC (Adriamycin, cyclophosphamide) chem...

Status

Completed

Location

National Cancer Institute (NCI)

Start Date

1994-05

Trial ID

NCT00001384

Treatments Being Tested

Adriamycin cyclophosphamide G-CSF paclitaxel

Previous Next